• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)感染持续时间:何时可以安全解除隔离?

Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation?

机构信息

Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.

Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.

出版信息

Clin Infect Dis. 2021 Apr 26;72(8):1467-1474. doi: 10.1093/cid/ciaa1249.

DOI:10.1093/cid/ciaa1249
PMID:33029620
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7499497/
Abstract

Defining the duration of infectivity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has major implications for public health and infection control practice in healthcare facilities. Early in the pandemic, most hospitals required 2 negative RT-PCR tests before discontinuing isolation in patients with Covid-19. Many patients, however, have persistently positive RT-PCR tests for weeks to months following clinical recovery, and multiple studies now indicate that these generally do not reflect replication-competent virus. SARS-CoV-2 appears to be most contagious around the time of symptom onset, and infectivity rapidly decreases thereafter to near-zero after about 10 days in mild-moderately ill patients and 15 days in severely-critically ill and immunocompromised patients. The longest interval associated with replication-competent virus thus far is 20 days from symptom onset. This review summarizes evidence-to-date on the duration of infectivity of SARS-CoV-2, and how this has informed evolving public health recommendations on when it is safe to discontinue isolation precautions.

摘要

确定严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的传染性持续时间对医疗机构中的公共卫生和感染控制实践具有重大意义。在大流行早期,大多数医院要求患有 Covid-19 的患者在停止隔离之前进行 2 次阴性 RT-PCR 检测。然而,许多患者在临床康复后数周到数月内持续进行 RT-PCR 检测呈阳性,多项研究表明这些通常不反映具有复制能力的病毒。SARS-CoV-2 似乎在症状出现时最具传染性,此后传染性迅速下降,大约在轻度至中度疾病患者中 10 天后和严重至危重病患者和免疫功能低下患者中 15 天后接近零。迄今为止与具有复制能力的病毒相关的最长间隔时间是从症状出现开始的 20 天。这篇综述总结了迄今为止关于 SARS-CoV-2 传染性持续时间的证据,以及这些证据如何为不断发展的关于何时安全停止隔离预防措施的公共卫生建议提供信息。

相似文献

1
Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation?严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)感染持续时间:何时可以安全解除隔离?
Clin Infect Dis. 2021 Apr 26;72(8):1467-1474. doi: 10.1093/cid/ciaa1249.
2
An in vitro model for assessment of SARS-CoV-2 infectivity by defining the correlation between virus isolation and quantitative PCR value: isolation success of SARS-CoV-2 from oropharyngeal swabs correlates negatively with Cq value.一种评估 SARS-CoV-2 感染性的体外模型,通过定义病毒分离与定量 PCR 值之间的相关性:从咽拭子中分离 SARS-CoV-2 的成功率与 Cq 值呈负相关。
Virol J. 2021 Apr 7;18(1):71. doi: 10.1186/s12985-021-01542-y.
3
SARS-CoV-2: The viral shedding vs infectivity dilemma.严重急性呼吸综合征冠状病毒2:病毒脱落与传染性的困境。
Infect Dis Health. 2020 Aug;25(3):210-215. doi: 10.1016/j.idh.2020.05.002. Epub 2020 May 20.
4
Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples.从诊断样本中预测传染性严重急性呼吸综合征冠状病毒 2。
Clin Infect Dis. 2020 Dec 17;71(10):2663-2666. doi: 10.1093/cid/ciaa638.
5
Coronaviruses - a new old menace.冠状病毒——新的旧威胁。
Postepy Biochem. 2021 Jan 5;66(4):303-308. doi: 10.18388/pb.2020_357. Print 2020 Dec 31.
6
Cell-based Culture Informs Infectivity and Safe De-Isolation Assessments in Patients with Coronavirus Disease 2019.基于细胞的培养可用于告知 2019 冠状病毒病患者的传染性和安全解除隔离评估。
Clin Infect Dis. 2021 Nov 2;73(9):e2952-e2959. doi: 10.1093/cid/ciaa1579.
7
Can Testing Predict SARS-CoV-2 Infectivity? The Potential for Certain Methods To Be Surrogates for Replication-Competent Virus.检测能否预测 SARS-CoV-2 的传染性?某些方法成为复制型病毒替代物的可能性。
J Clin Microbiol. 2021 Oct 19;59(11):e0046921. doi: 10.1128/JCM.00469-21. Epub 2021 Aug 4.
8
Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients.糖尿病是危重症患者下呼吸道样本中 SARS-CoV-2 病毒持续脱落的一个风险因素。
Endocrine. 2020 Dec;70(3):454-460. doi: 10.1007/s12020-020-02465-4. Epub 2020 Sep 1.
9
[SARS-CoV-2 and Microbiological Diagnostic Dynamics in COVID-19 Pandemic].[严重急性呼吸综合征冠状病毒2与2019冠状病毒病大流行中的微生物诊断动态]
Mikrobiyol Bul. 2020 Jul;54(3):497-509. doi: 10.5578/mb.69839.
10
Dynamics of viral RNA load, virus culture, seroconversion & infectivity in COVID-19 patients: Implications on isolation policy.新型冠状病毒感染患者的病毒 RNA 载量、病毒培养、血清转化和传染性动力学:对隔离政策的影响。
Indian J Med Res. 2021;153(5&6):585-590. doi: 10.4103/ijmr.IJMR_3564_20.

引用本文的文献

1
Cognitively-plausible reinforcement learning in epidemiological agent-based simulations.基于代理的流行病学模拟中认知合理的强化学习
Front Epidemiol. 2025 Jul 28;5:1563731. doi: 10.3389/fepid.2025.1563731. eCollection 2025.
2
Reagent efficiency and analytical sensitivity optimization for a reliable SARS-CoV-2 pool-based testing strategy.基于可靠的SARS-CoV-2混合检测策略的试剂效率和分析灵敏度优化
Heliyon. 2025 Jan 2;11(1):e41623. doi: 10.1016/j.heliyon.2025.e41623. eCollection 2025 Jan 15.
3
Deisolation in the Healthcare Setting Following Recent COVID-19 Infection.近期感染 COVID-19 后的医疗环境去隔离化。
Viruses. 2024 Jul 15;16(7):1131. doi: 10.3390/v16071131.
4
Completion rates and myelosuppression degrees of cancer patients receiving radiotherapy or chemoradiotherapy unchanged regardless of delay duration after Omicron infection.无论奥密克戎感染后延迟时间长短如何,接受放疗或放化疗的癌症患者的完成率和骨髓抑制程度均无变化。
Sci Rep. 2024 Jun 20;14(1):14226. doi: 10.1038/s41598-024-65019-y.
5
Pathophysiological, immunological, and inflammatory features of long COVID.长新冠的病理生理、免疫和炎症特征。
Front Immunol. 2024 Feb 28;15:1341600. doi: 10.3389/fimmu.2024.1341600. eCollection 2024.
6
Transmission risk of asymptomatic SARS-CoV-2 infection: a systematic review and meta-analysis.无症状SARS-CoV-2感染的传播风险:一项系统综述和荟萃分析。
Infect Med (Beijing). 2023 Mar;2(1):11-18. doi: 10.1016/j.imj.2022.12.001. Epub 2022 Dec 17.
7
The efficacy of hydrogen/oxygen therapy favored the recovery of omicron SARS-CoV-2 variant infection: results of a multicenter, randomized, controlled trial.氢/氧疗法对奥密克戎SARS-CoV-2变种感染的恢复具有促进作用:一项多中心、随机、对照试验的结果
J Clin Biochem Nutr. 2023 Nov;73(3):228-233. doi: 10.3164/jcbn.23-32. Epub 2023 Aug 18.
8
Predictions from standard epidemiological models of consequences of segregating and isolating vulnerable people into care facilities.预测将弱势群体隔离和安置到护理机构的后果的标准流行病学模型。
PLoS One. 2023 Oct 30;18(10):e0293556. doi: 10.1371/journal.pone.0293556. eCollection 2023.
9
ANCOC Score to Predict Mortality in Different SARS-CoV-2 Variants and Vaccination Status.用于预测不同SARS-CoV-2变体和疫苗接种状态下死亡率的ANCOC评分
J Clin Med. 2023 Sep 8;12(18):5838. doi: 10.3390/jcm12185838.
10
Impact and management of COVID-19 in liver transplant candidates and recipients.新型冠状病毒肺炎对肝移植候选者及受者的影响与管理
Ann Gastroenterol. 2023 Sep-Oct;36(5):477-489. doi: 10.20524/aog.2023.0815. Epub 2023 Jul 3.